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Abstract 
BACKGROUND: Acute respiratory infections (ARI) are one of the prevalent pediatric diseases. Coinfections of 
respiratory viruses and atypical bacterial respiratory pathogens are common. 
AIM: This study aimed to determine the prevalence of co-infection between respiratory pathogens including 
viruses, bacteria and atypical bacteria in a sample of Egyptian children presenting with symptoms of acute 
respiratory tract infection. 
METHODS: This one-year prospective cohort study conducted in Abo El Rish Pediatric Hospital, Cairo University 
over one year included children presenting with symptoms of acute respiratory infection. Enrolled children were 
subjected to nasopharyngeal swabs or throat swabs and then processed to detect viral, bacterial and atypical 
bacterial causative agents by culture), retrotranscription polymerase, Monoplex polymerase chain reaction (PCR) 
and Multiplex PCR. 
RESULTS: Viral etiological agents were detected in 20 cases (20.8%), while 76 patients (79.2%) had no definite 
viral aetiology. The most abundant virus detected was Rhinovirus in 36 (27.3%), followed by 21 (15.9%) were 
positive for RSV, 12 (9.1%) were positive for HMPV, 6 (4.5%) were positive for adenovirus and 3 (2.3%) were 
positive for influenza B. For Atypical bacterial causes Mycoplasma were positive for 9 (6.8%) cases and one case 
was positive for Bordetella parapertussis. Viral and atypical bacteria Co infection were detected in 14 (10.6%) of 
cases. 
CONCLUSION: These results suggest that coinfection with bacteria or atypical bacteria in children with acute 
respiratory tract infection is common and this co-infection can induce serious illness. The multiplex reverse-
transcriptase polymerase chain reaction should become an essential tool for epidemiological studies and can fill 
the gap between clinical presentation and definitive diagnosis. 
 
 
 
 
 
Introduction 
 
Acute respiratory infections (ARI) are one of 
the prevalent pediatric diseases all over the world. In 
children below five years [1] [2] [3), acute respiratory 
infections are responsible for 18–33% of all deaths. 
Unfortunately, more than half of this mortality is 
recorded among developing countries as low social 
level and malnutrition double the burden [2] [3] [4]. 
Acute respiratory infections can be caused by 
pathogens like bacteria, viruses, fungal and atypical 
bacteria include Streptococcus pneumoniae, 
Mycoplasma pneumoniae, Haemophilus influenzae, 
and respiratory viruses (influenza A and B, 
adenovirus, respiratory syncytial virus and 
parainfluenza) [5] [6]. 
Although viruses are usually the main 
responsible for most of both upper and lower acute 
respiratory infections (ARIs) [7], but studies 
documented that patients may be infected with both 
bacterial and viral pathogens, making it difficult to 
identify the clinical characteristics that allow the 
physician to differentiate viral disease from bacterial 
disease in the early course of the disease [8]. 
Recently, many new emerging respiratory 
viruses have been identified including human 
coronavirus (HCoV), NL63 [9] and human bocavirus 
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(HBoV) [10]. Moreover, various emerging respiratory 
viruses led to epidemics and pandemic (H1N1) virus 
infection and H5N1 [11]. 
Atypical pathogens Mycoplasma pneumoniae, 
Chlamydophila pneumoniae, and Legionella 
pneumophila are considered important agents are 
causing mild, moderate, or even severe acute 
respiratory tract infections (ARTIs) in children 
worldwide [12]. 
This study aimed to determine the prevalence 
of co-infection distribution between respiratory 
pathogens including viruses and atypical bacteria 
among a well cohort of febrile children presenting by 
acute respiratory tract infections symptoms. 
 
 
Material and Methods 
 
This one-year prospective cohort study 
conducted in Abo El Rish Pediatric Hospital, Cairo 
University over one year from the first of June 2016 to 
30th of June 2017 on children presenting with 
symptoms of acute respiratory infection.  
 
Ethical statement 
The study followed the regulations of the 
medical ethical committee of the Cairo University and 
the medical ethical committee of the National 
Research Centre and. Signed informed consents were 
collected from legal child guardian before participation 
after explaining the purpose of the study. 
Any child presented with Influenza-like illness 
(ILI) symptoms the chest clinic Abo El Rish Pediatric 
Hospital, Cairo University was considered eligible. ILI 
was defined according to CDC criteria as having 
measured fever > 38˚C and cough and/or a sore 
throat [13]. 
 
Exclusion criteria 
Any child receiving immunosuppressive 
therapy started antibiotic therapy, children with 
chronic lung diseases and patients who were unwilling 
to participate in this study were excluded from the 
study.  
 
Data collection 
Data were collected by a self-designed 
questionnaire include demographic data, risk factors 
(smoking, passive smoking and contact with birds). 
Throat washes and nasal swabs were collected from 
each child as appropriate. 
 
Laboratory analysis 
For Routine Bacterial and fungal culture 
A throat wash was taken from each child 
when appropriate, in the case of a young infant throat 
swab was taken instead.  
Specimens then were cultured on blood agar, 
chocolate agar, MacConkey agar and Sabarauds 
dextrose agar (Oxoid Co. England). Isolates were 
identified by conventional methods such as culture 
characteristics and biochemical reactions. 
 
For Viral PCR 
Nasopharyngeal swabs were taken from each 
participant by measuring the distance between the ear 
lobule and the ala nasi by the NP swab and divided by 
2, and the swab marked at this distance to ensure the 
insertion of the swab in the proper site. This flexible, 
sterile tip flocked with nylon fibre swab applicator was 
inserted into the nostril and back to the nasopharynx 
and left in place for a few seconds. It was then slowly 
withdrawn with a rotating motion. The swab was 
placed in a 15 mL centrifuge tube labelled with the 
unique patient ID and containing 2 mL viral transport 
media (VTM: consisting of a sterile solution of bovine 
albumin fraction V, HEPES buffer, penicillin and 
streptomycin in HANK’s balanced salt solution). The 
applicator stick was then cut off.  
The received swabs inside the 15 ml tube 
were agitated vigorously for 10 seconds using a 
vortex mixer to free cells from the swab tip, and then 
swab was removed from the tube and discarded using 
a forceps. The VTM was immediately placed in a 
freezer (-70°C) until tested with PCR for the presence 
of respiratory viruses. If samples are positive for 
Influenza A, then further testing was performed by 
PCR to determine if the virus is a seasonal influenza 
variant or swine H1N1 2009 virus. 
 
PCR testing for Respiratory viruses 
Viral Nucleic Acid Extraction: Viral Nucleic 
acid extraction was done after centrifugation of the 
sample for 10-20 min and 200ul from the sediment 
taking as starting material using the QIAamp® Viral 
RNA Mini cat number 52904 according to the 
manufacturer’s instructions. Elution was done with 
60ul buffer AVE, and reelution step was added to 
increase the nucleic acid concentration. 
CDNe was done using 15ul from the extracted 
RNA, for only the testing of the following RNA viruses 
(Rhinovirus, Influenza, RSV and HMPV). For 
Adenovirus conventional PCR testing was done 
directly from the extracted nucleic acid (DNA). The kit 
used for complementary DNA synthesis was Sensifast 
cDNA (cat# BIO-65054).  
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PCR: Conventional PCR was done by 3 
different reactions for each sample as follows for the 
following viruses: 
 Monoplex PCR for Rhinovirus testing 
using primers sequence, concentrations 
and conditions as [14]; 
 Monoplex PCR for Adenovirus testing 
using primers sequence, concentrations 
and conditions as [14]; 
 Multiplex PCR for InfA, InfB, HMPV and 
RSV testing from the following work [15] 
(Table 1). 
Table 1: Primer list for detection of Respiratory viruses by 
different PCR types 
Virus-
tested  
Type of 
PCR Primers 
Final 
Primers 
Conc  
Master Mix 
used 
Annealing 
Temp 
Ref 
Rhino Monoplex EVP4  5’-CTACTTTGGTGTCCGTGTT-3’  0.2M One Taq 
Hot Start 
Quick-Load 
2X Master 
Mix 
(M0488S) 
55C [2] 
OL68-1  5’-GGTAAYTTCCACCACCANCC-3’  
Adenovirus  Monoplex AdnU-
S’2  
5’-TTCCCCATGGCNCACAAYAC-3’  0.2M One Taq 
Hot Start 
Quick-Load 
2X Master 
Mix 
(M0488S) 
59C [2] 
AdnU 5’-TGCCKRCTCATRGGCTGRAAGTT-
3’  
InFA and 
B, RSV 
HMPV 
Multiplex RSV vrs 
P1 
GGA ACA AGT TGT TGAGGT 
TTA TGA ATA TGC 
0.3M Qiagen 
multiplex 
MM 
55C [1] 
vrs 
P2 
TTC TGC TGT CAA GTC TAG 
TAC ACT GTA GT 
InFA mia 1 CAG AGA CTT GAA GAT GTC 
TTT GCT GG  
0.3M 
mia 2  GCT CTG TCC ATG TTA TTT 
G  
InfB  mib 1  AAA ATT ACA CTG TTG GTT 
CGG TG  
0.3M 
mib 2  AGC GTT CCT AGT TTT ACT 
TG  
hMPV  
 
hmpv 
1  
CCC TTT GTT TCA GGC CAA  0.3M 
hmpv 
2  
GCA GCT TCA ACA GTA GCT 
G  
 
 
Statistical method 
Data were coded and entered using the statistical 
package SPSS (Statistical Package for the Social 
Sciences) version 23. Data were summarised using 
mean, standard deviation, median, minimum and 
maximum in quantitative data and using frequency 
(count) and relative frequency (percentage) 
 
 
Results  
 
The study was conducted from first June 2016 
to June 2017. 132 children presented by ILI were 
enrolled in the study selected from Pediatric Hospital 
Cairo University. 57 (43.2%) were males, and 75 
(56.8%) were females. 
The age of patients ranged from 1month-10 
years (120 months) with a mean age of 2.95 ± 2.46 
years (Table 2), this study was designed to estimate 
the prevalence of respiratory pathogens in 132 
children presented with ARI. Overall, samples from 
114 individuals (86.3%) were found to be positive for 
at least one pathogen, and 18 of them were positive 
for two or more pathogens. Rhinovirus was the most 
commonly detected agent, followed by Streptococcus 
pneumoniae. 
Table 2: Demographic data of the studied children 
Age (months) 
 Mean 
±SD 
29.34 ± 28.29 
 Range 1-120 
 Frequency  Percentage 
Gender  
 Female  57 43.2% 
 Male 75 56.8% 
Exposure to smoking    
 Yes 63 62.8% 
 No 49 37.1% 
Exposure to birds 
 Yes 61 46.2% 
 No 71 53.8% 
 
Viral etiological agents were detected in 78 
cases (59.09%), while 54 patients (40.9%) had no 
definite viral aetiology. The most abundant virus 
detected was Rhinovirus in 36 (27.3%), followed by 21 
(15.9%) were positive for RSV, 12 (9.1%) were 
positive for HMPV, 6 (4.5%) were positive for 
adenovirus and 3 (2.3%) were positive for influenza B 
(Table 3). 
Table 3: Etiological agents detected in the studied children 
Etiological agents Frequency Percentage 
Viral agents 
Rhinovirus 36 27.3 
RSV 21 15.9 
HMPV 12 9.1 
Inf A 0 0 
Inf B 3 2.3 
Adenovirus 6 4.5 
Bacterial agents   
Klebsiella 17 12.9 
Enterobacter 11 8.3 
Pseudomonas spp. 11 8.3 
Acinetobacter 9 6.8 
Klebsiella and enterobacter 1 0.8 
Atypical bacteria agents 
Chlamydophila pneumoniae 0 0 
Bordetella parapertussis 1 0.8 
Bordetella pertussis 0 0 
Legionella pneumophila 0 0 
Mycoplasma pneumoniae 9 6.8 
 
Bacterial agents were detected in 49 cases 
(37.1%), Klebsiella was detected in 17 (12.9%) child 
followed by Enterobacter in 11 (8.3%), Pseudomonas 
spp. 11 (8.3%), Acinetobacter 9 (6.8%) and Klebsiella 
and Enterobacter co-infection in one child (0.8%). 
For Atypical bacterial causes, Mycoplasma 
was positive for 9 (6.8%) cases, and one case was 
positive for Bordetella parapertussis (Table 3). 
Table 4: Co-infection distribution among studied cases 
Co-infection No 
Streptococcus pneumoniae, mycoplasm, Rhinovirus and HMPV 3 
Streptococcus pneumoniae, and Rhinovirus 1 
Streptococcus pneumoniae, Rhinovirus and HMPV  2 
Streptococcus pneumoniae and Rhinovirus 6 
Rhinovirus and HMPV  3 
Mycoplasm and RSV  3 
 
Viral and atypical bacteria Co infection were 
detected in 14 cases illustrated in Table 4.  
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Discussion 
 
Acute respiratory disease present about 75% 
of all acute morbidities in developed countries, and 
most of the cases (about 80%) are viral [16]. On 
average, five to eight respiratory viruses are detected 
in pediatric patients every year [17] [18]. These 
viruses are well-known causes of acute respiratory 
tract 6+03infections (ARTIs), which are a major 
source of morbidity and mortality in infants and young 
children [19]. 
The PCR technology development allowed a 
wide range of etiological viral agents to be detected 
with more sensitivity and specificity [20].  
Several recent studies have analysed the 
epidemiologic pattern of respiratory viral infections; 
Rhinovirus is usually the most common single 
pathogen found in ARI surveillances samples with 
prevalence range 24. -50% followed by RSV 22-25% 
and influenza viruses 7.2-8% either by detection in 
nasal washes or nasopharyngeal swabs [21] [22] [23], 
which comes in accordance with an Egyptian study by 
Amin et al., 2012 RSV virus was detected with a high 
predominance (51.9%) in Egyptian asthmatic children 
with acute respiratory tract infection [24]. 
In the current study, the most abundant virus 
detected was Rhinovirus in 36 positive samples 
(27.3%), followed by RSV in 21 (15.9%) positive 
samples. Although it is non-statistically significant, all 
the positive cases are distributed all over different age 
group.  
Human metapneumovirus (HMPV) is a 
recently identified Paramyxovirus first isolated from 
hospitalised children with acute respiratory tract 
infections (ARTI) in 2001 [25] Since then the hMPV 
reported prevalence ranged between 1.5 to 17.5% 
[26].  
In the current study positive samples for 
hMPV was 12 (9.1%), This ratio may be considered 
lower than similar studies [26] [27] [28] and that can 
be explained by that child included in our study were 
enrolled from the patient presenting by ILI symptoms 
and the hMPV is more common in hospitalized 
children with pneumonia . 
The dual viral infection or the multiple viral 
isolates occurrence was reported by some studies 
[29] [30] on the contrary; other studies failed to detect 
more than one viral agent [24]. In our study, we 
reported 3 cases of rhino and hMPV dual viral 
infection. 
Atypical bacteria as Mycoplasma 
pneumoniae, Bordetella parapertussis and Chlamydia 
pneumoniae are common respiratory pathogens in 
children 5 years of age and older [31]. Infection may 
be preceded by an upper respiratory infection. Of the 
132-child presented by ILI in our study 9 (6.8%) 
children were positive for Mycoplasma pneumoniae, 
and one case (0.8%) was positive to Bordetella 
parapertussis. 
Coinfections with respiratory viruses and 
bacterial respiratory pathogens are common, often via 
synergistic interactions between the viruses like 
influenza virus, the bacteria, and the human host, 
However, the interaction between viruses and atypical 
bacteria still unexplained [32].  
This study aimed to demonstrate the rate of 
co-infection between viral and bacterial agent. 
Although all the children enrolled in this study had the 
similar initial clinical presentation but the causative 
agent varied from single or multiple and bacterial or 
viral . 
Viral and bacterial Co-infection was detected 
in 18 (22.7%) of children in the current study, of them 
6 children were positive to Rhinovirus and another 
agent either bacterial (Streptococcus pneumoniae), 
atypical bacteria (Mycoplasma), viral (HMPV) or 
multiple causative agents. 
The dual infection or multiple causative agent 
infections had been studied evidently in recent 
researches as multiplex PCR enabled laboratorians to 
detect a panel of viruses simultaneously while 
reducing hands-on time and with greater analytical 
sensitivity. There are several multiplex assays 
evaluated for detection of respiratory viruses [33]. 
In a study on respiratory pathogens in 
hospitalized children, of 1281 children, 449 (35%) had 
an acute respiratory tract infection caused by at least 
one of the organisms studied; there were 29 cases of 
dual infection [34]. In another study Serology with 
paired samples and PCR on nasopharyngeal 
aspirates and throat cultures were used to identify 
bacteria and viruses and mixed viral/bacterial 
pathogens in 26 patients (20.5%) The main etiological 
agents were adenovirus, respiratory syncytial virus 
(RSV), Mycoplasma pneumoniae, Streptococcus 
pyogenes and Chlamydia pneumoniae [35]. 
These results suggest that coinfection with 
bacteria or atypical bacteria in children with acute 
respiratory tract infection is common and this co 
infection can induce serious illness. 
Unfortunately, most of respiratory tract 
infection are still treated empirically [36] with antibiotic 
in spite that most of the causative agents are viral on 
the other hand Most of pneumonia caused by atypical 
bacteria usually occurs after infection of the upper 
respiratory tract [32].  
Certainly, the early management of 
respiratory tract infection is essential to ensure good 
prognosis and avoid complications. The diagnosis 
based on clinical finding alone is no more suitable the 
need of non-traditional diagnostic test now is 
becoming a must as molecular methods such as 
multiplex Real-Time PCR (RT-PCR) facilitate 
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identifying many causative agents which in turn 
reduce the excessive use antibiotics has caused rising 
bacterial resistance. 
The multiplex reverse-transcriptase 
polymerase chain reaction should become an 
important tool for epidemiological studies and can fill 
the gap between clinical presentation and definitive 
diagnosis. 
In conclusion, co-infection with multiple 
pathogens with the predominance of viruses is 
emerging. The Large-scale multicentric studies are 
recommended to address the epidemiological gap, 
and hence a new management strategy can be 
developed. 
 
Limitation of the study 
Small sample size and a low number of co-
infection cases preclude any robust statistical 
analysis. 
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